Immune checkpoint inhibitors in renal cell carcinoma
K Ross, RJ Jones - Clinical Science, 2017 - portlandpress.com
The immune system has long been known to play a critical role in the body's defence
against cancer, and there have been multiple attempts to harness it for therapeutic gain …
against cancer, and there have been multiple attempts to harness it for therapeutic gain …
PD-1 immunotherapy in pancreatic cancer: current status
Pancreatic ductal adenocarcinoma is the known kind of tumor biologically featured as high
malignant degree, lack of effective methods for diagnosis and treatment, which reflects its …
malignant degree, lack of effective methods for diagnosis and treatment, which reflects its …
Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection
M Flynn, L Pickering, J Larkin… - … Advances in Medical …, 2018 - journals.sagepub.com
Immune-checkpoint inhibitors (ICPIs), including antibodies against cytotoxic T-lymphocyte
associated antigen 4 and programmed cell death protein 1, have been shown to induce …
associated antigen 4 and programmed cell death protein 1, have been shown to induce …
Cancer immunotherapy: new applications in urologic oncology
ME Hurwitz, J Sokhn, DP Petrylak - Current Opinion in Urology, 2016 - journals.lww.com
Cancer immunotherapy: new applications in urologic oncology : Current Opinion in Urology
Cancer immunotherapy: new applications in urologic oncology : Current Opinion in Urology Log …
Cancer immunotherapy: new applications in urologic oncology : Current Opinion in Urology Log …